Intellectual Property: patents (contentious & non-contentious) - "Andrew has been identified as a key name to note."
Andrew is a partner in the Patents & Innovation team and offers expert counsel on contentious patent and regulatory matters.
Leveraging his previous experience as a medicinal chemist in the pharmaceutical industry, he is particularly focused on advising companies within the life sciences sector and is recognised by clients for his extensive industry knowledge.
Declaratory Relief in the English Patents Court, Bio-Science Law Review, 2016, p 123-128
Patents Overhauled: Impact of the America Invents Act on the Pharmaceutical Industry (co-author), European Biopharmaceutical Review, Spring 2015
New and Approved: The New EU Clinical Trials Regulation (co-author), European Pharmaceutical Contractor, December 2014 p 50-53
Intellectual Property: patents (contentious & non-contentious) - "Andrew has been identified as a key name to note."
von mehreren Autoren
Brexit and beyond – Wellcome's recommendations from the Future Partnership Project
von Andrew Payne
Licence held to be exclusive despite option
von Andrew Payne
von Dr. Benedikt Rohrßen und Jan Seebass
von mehreren Autoren
von Louise Popple
von Karlijn van Laar
von Sophia Louw und Natalia Faekova
von mehreren Autoren
von Dr. Benedikt Rohrßen und Jan Seebass
von Alexandra Boreham und Tom Charnley